Cancer care is one of the most complex and expensive parts of employee healthcare. Decisions are made quickly, often before patients understand their options.

In this episode, Nancy Ryerson speaks with Yousuf Zafar, MD, MHS, Chief Medical Officer at AccessHope, about where cancer care breaks down and what actually changes outcomes. They explore why even experienced oncologists struggle to stay current, why patients rarely seek out second opinions, and how access to subspecialty expertise can improve care without forcing employees to travel.

In this episode, you'll learn:

• Why many patients never receive subspecialty input
• The role expert review plays without disrupting local care
• The connection between better care decisions and long-term cost control

Highlights:

(00:00) Meet Yousuf Zafar

(01:19) What happens when expert review changes the course of cancer treatment

(03:42) Why even experienced oncologists can’t keep up

(05:27) Community oncology vs. academic cancer centers

(07:39) How patients choose care right after diagnosis

(08:05) Bringing subspecialty expertise to local cancer care

(10:27) Why second opinions rarely happen

(12:15) What’s really driving rising cancer costs

(18:05) How better care can lower long-term costs

(34:40) Advice for benefits leaders navigating cancer care

Resources:

Nancy Ryerson’s LinkedIn: https://www.linkedin.com/in/nancyryerson/

Yousuf Zafar’s LinkedIn: https://www.linkedin.com/in/yousufzafar/

AccessHope’s website: https://www.myaccesshope.org/